Advances in research on 3C-like protease (3CL pro ) inhibitors against SARS-CoV-2 since 2020
Roufen Chen, Yali Gao, Han Liu, He Li, Wen‐Fa Chen, Junjie Ma · RSC Medicinal Chemistry · 2022
The representative SARS-CoV-2 3CL pro inhibitors reported since 2020 and their biological activities and binding models are reviewed, providing new insights into the design and development of more effective 3CL pro inhibitors against SARS-CoV-2.